Janney Montgomery Scott LLC Increases Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Janney Montgomery Scott LLC increased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 45.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 43,203 shares of the medical instruments supplier’s stock after purchasing an additional 13,491 shares during the quarter. Janney Montgomery Scott LLC’s holdings in DENTSPLY SIRONA were worth $1,169,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the business. First Eagle Investment Management LLC lifted its stake in DENTSPLY SIRONA by 33.6% during the second quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock worth $325,571,000 after purchasing an additional 3,283,965 shares during the last quarter. Nuance Investments LLC lifted its stake in DENTSPLY SIRONA by 3.8% during the second quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock worth $271,019,000 after purchasing an additional 402,329 shares during the last quarter. Cooke & Bieler LP increased its position in DENTSPLY SIRONA by 16.2% during the second quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after buying an additional 1,046,105 shares during the period. Price T Rowe Associates Inc. MD increased its position in DENTSPLY SIRONA by 5.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 6,266,781 shares of the medical instruments supplier’s stock worth $207,995,000 after buying an additional 343,915 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in DENTSPLY SIRONA by 42.0% during the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock worth $110,118,000 after buying an additional 1,308,411 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have commented on XRAY shares. Evercore ISI cut their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Barrington Research cut their price target on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research report on Friday, November 8th. Leerink Partners lowered DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Robert W. Baird dropped their target price on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday, November 8th. Finally, Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Six analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $29.50.

DENTSPLY SIRONA Trading Up 2.3 %

Shares of DENTSPLY SIRONA stock opened at $18.28 on Friday. DENTSPLY SIRONA Inc. has a fifty-two week low of $17.21 and a fifty-two week high of $37.60. The firm has a market cap of $3.63 billion, a PE ratio of -8.83, a P/E/G ratio of 1.70 and a beta of 1.02. The business’s fifty day moving average is $23.92 and its two-hundred day moving average is $25.45. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. During the same quarter in the prior year, the company posted $0.49 EPS. The business’s revenue for the quarter was up .4% compared to the same quarter last year. Analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.